ABSTRACT
Sample preparation for mass-spectrometry-based proteomic analyses usually requires intricate, multistep workflows that are often limited in capacity or suffer from sample loss. Here, we introduce a lean adsorption-based protocol (ABP) for the extraction of proteins from fresh cell lysates that enables us to modify and tag protein samples under harsh conditions, such as organic solvents, high salt concentrations, or low pH values. This offers high versatility while also reducing the required steps in the preparation process significantly. Protein identifications are slightly increased compared to traditional acetone precipitation followed by an in-solution digestion (AP/IS) or filter aided sample preparation (FASP) and proved complementary to both methods regarding proteome coverage. When combined with ArgC-like digestion, this approach delivered 5386 uniquely identified proteins, a substantial increase of 18.27% over tryptic digestion (4554), while decreasing spectra complexity due to a lower number of peptide to spectra matches per protein and the number of missed cleaved peptides. In addition, an increased number of identified membrane proteins and histones as well as improved fragmentation and intensity coverage were observed through comprehensive data analysis.
Subject(s)
Aldehyde Oxidoreductases/pharmacology , Bacterial Proteins/pharmacology , Proteins/isolation & purification , Proteome/isolation & purification , Proteomics/methods , Acetone/chemistry , Aldehyde Oxidoreductases/chemistry , Bacterial Proteins/chemistry , Chemical Precipitation , Escherichia coli/enzymology , HEK293 Cells , Humans , Hydrogen-Ion Concentration , Proteins/chemistry , Proteome/chemistry , Silicon Dioxide/chemistry , Solvents/chemistry , Transferrin/chemistryABSTRACT
Birch pollen allergy is diagnosed and treated with aqueous extracts from birch pollen, which contain a mixture of allergens and nonallergenic proteins, including large numbers of closely related sequence variants, so-called iso-allergens of the major allergen, Bet v 1. The quality of therapeutic and diagnostic allergen products largely depends on the allergen and iso-allergen composition. Several biochemical methods are currently applied to detect and quantify allergens and to record protein profiles without differentiating between iso-allergens. Mass spectrometry (MS) may entirely replace these technologies, as it allows sequence specific identification and quantification of proteins and protein profiles including sequence variants in one run. However, the protein inference problem still hampers the automatic assignment of peptide sequences to proteins, consequently impeding the quantification of sequence variants. Therefore, the aim of the study was to set up semitargeted analyses of label-free MS data that allow unambiguous identification and quantification of birch pollen allergens and nonallergenic proteins. We combined data independent acquisition with manual assignment of predefined target sequences for quantification of iso-allergens and automatic quantification of other allergens and nonallergenic proteins. The quantitative data for birch pollen allergens and sequence variants of Bet v 1 were further confirmed by multiple reaction monitoring.
Subject(s)
Antigens, Plant/chemistry , Betula/adverse effects , Hypersensitivity/diagnosis , Plant Proteins/chemistry , Allergens/adverse effects , Allergens/immunology , Antigens, Plant/immunology , Betula/chemistry , Betula/immunology , Humans , Hypersensitivity/drug therapy , Hypersensitivity/immunology , Immunoglobulin E/immunology , Mass Spectrometry , Plant Proteins/immunology , Pollen/adverse effects , Pollen/immunology , Quality ControlABSTRACT
Allergy against birch pollen is among the most common causes of spring pollinosis in Europe and is diagnosed and treated using extracts from natural sources. Quality control is crucial for safe and effective diagnosis and treatment. However, current methods are very difficult to standardize and do not address individual allergen or isoallergen composition. MS provides information regarding selected proteins or the entire proteome and could overcome the aforementioned limitations. We studied the proteome of birch pollen, focusing on allergens and isoallergens, to clarify which of the 93 published sequence variants of the major allergen, Bet v 1, are expressed as proteins within one source material in parallel. The unexpectedly complex Bet v 1 isoallergen composition required manual data interpretation and a specific design of databases, as current database search engines fail to unambiguously assign spectra to highly homologous, partially identical proteins. We identified 47 non-allergenic proteins and all 5 known birch pollen allergens, and unambiguously proved the existence of 18 Bet v 1 isoallergens and variants by manual data analysis. This highly complex isoallergen composition raises questions whether isoallergens can be ignored or must be included for the quality control of allergen products, and which data analysis strategies are to be applied.
Subject(s)
Anti-Allergic Agents/chemistry , Antigens, Plant/immunology , Pollen/immunology , Quality Control , Rhinitis, Allergic, Seasonal/drug therapy , Anti-Allergic Agents/therapeutic use , Databases, Factual , Mass Spectrometry , Material Safety Data Sheets , Rhinitis, Allergic, Seasonal/immunologyABSTRACT
Frankincense preparations, used in folk medicine to cure inflammatory diseases, showed anti-inflammatory effectiveness in animal models and clinical trials. Boswellic acids (BAs) constitute major pharmacological principles of frankincense, but their targets and the underlying molecular modes of action are still unclear. Using a BA-affinity Sepharose matrix, a 26-kDa protein was selectively precipitated from human neutrophils and identified as the lysosomal protease cathepsin G (catG) by mass spectrometry (MALDI-TOF) and by immunological analysis. In rigid automated molecular docking experiments BAs tightly bound to the active center of catG, occupying the same part of the binding site as the synthetic catG inhibitor JNJ-10311795 (2-[3-[methyl[1-(2-naphthoyl)piperidin-4-yl]amino]carbonyl)-2-naphthyl]-1-(1-naphthyl)-2-oxoethylphosphonic acid). BAs potently suppressed the proteolytic activity of catG (IC(50) of approximately 600 nM) in a competitive and reversible manner. Related serine proteases were significantly less sensitive against BAs (leukocyte elastase, chymotrypsin, proteinase-3) or not affected (tryptase, chymase). BAs inhibited chemoinvasion but not chemotaxis of challenged neutrophils, and they suppressed Ca(2+) mobilization in human platelets induced by isolated catG or by catG released from activated neutrophils. Finally, oral administration of defined frankincense extracts significantly reduced catG activities in human blood ex vivo vs placebo. In conclusion, we show that catG is a functional and pharmacologically relevant target of BAs, and interference with catG could explain some of the anti-inflammatory properties of frankincense.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Boswellia/physiology , Cathepsins/metabolism , Serine Endopeptidases/metabolism , Triterpenes/pharmacology , Adult , Amino Acid Sequence , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Binding, Competitive , Boswellia/metabolism , Cathepsin G , Cathepsins/antagonists & inhibitors , Cathepsins/blood , Drug Delivery Systems , Humans , Hydrolysis/drug effects , Molecular Sequence Data , Plant Extracts/administration & dosage , Plant Extracts/metabolism , Plant Extracts/pharmacology , Protein Binding , Serine Endopeptidases/blood , Triterpenes/administration & dosage , Triterpenes/metabolismABSTRACT
Hyperforin, the major active constituent of St. John Wort (SJW) extract, affects several neurotransmitter systems in the brain putatively by modulation of the physical state of neuronal membranes. Accordingly, we tested the effects of SJW extract and of hyperforin on the properties of murine brain membrane fluidity. Oral administration of SJW extract and of hyperforin sodium salt results in significant hyperforin brain levels. Treatment of mice with hyperforin leads to decreased annular- and bulk fluidity and increased acyl-chain flexibility of brain membranes. All hyperforin related changes of membrane properties were significantly correlated with the corresponding hyperforin brain levels. Our data emphasises a membrane interaction of hyperforin that possibly contributes to its pharmacological effects.
Subject(s)
Cell Membrane/drug effects , Hypericum/chemistry , Neurons/drug effects , Terpenes/pharmacology , Administration, Oral , Animals , Anisotropy , Brain/cytology , Brain/drug effects , Brain Chemistry/drug effects , Bridged Bicyclo Compounds , Cell Membrane/metabolism , Chromatography, Liquid/methods , Diphenylhexatriene , Dose-Response Relationship, Drug , Female , Membrane Fluidity/drug effects , Mice , Neurons/cytology , Phloroglucinol/analogs & derivatives , Plant Extracts/pharmacology , Pyrenes , Terpenes/metabolismABSTRACT
Even though the degradation of ginsenosides has been thoroughly studied in animals and in vitro using acids, enzymes, and intestinal bacteria, knowledge concerning the systemic availability of ginsenosides and their degradation products in humans is generally lacking. Therefore, the attention in this article is focused on the identification of ginsenosides and their hydrolysis products reaching the systemic circulation in man. This is of great importance in understanding clinical effects, preventing herb-drug interactions, and optimizing the biopharmaceutical properties of ginseng preparations. Using a sensitive mass spectrometric method, which is specific for the identification of ginsenosides in complex biological matrices, the degradation pathway of ginsenosides in the gastrointestinal tract of humans could be elucidated following the oral administration of ginseng. Within the frame of a pilot study, human plasma and urine samples of two subjects were screened for ginsenosides and their possible degradation products. In general, the urine data coincided well with the plasma data. In both volunteers the same hydrolysis products, which are not originally present in the Ginsana extract (Pharmaton S.A., Lugano, Switzerland) ingested, were identified in plasma and urine. It was shown that two hydrolysis products of the protopanaxatriol ginsenosides, namely G-Rh1 and G-F1 may reach the systemic circulation. In addition, compound-K, the main intestinal bacterial metabolite of the protopanaxadiol ginsenosides, was detected in plasma and urine. These products are probably responsible for the action of ginseng in humans. In opposition to previous reports, G-Rb1 was identified in plasma and urine of one subject.